Higher-Valent Pneumococcal Conjugate Vaccines-Perspective for 2026

Liset Olarte^{1

2}, Daniel M Musher^{3

4}, Maria C Rodriguez-Barradas^{3

4}

Affiliations

¹ Division of Infectious Diseases, Texas Children's Hospital, Houston.
² Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
³ Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
⁴ Department of Medicine, Baylor College of Medicine, Houston, Texas.

Liset Olarte et al. JAMA Intern Med. 2025.

. 2025 Oct 20.

doi: 10.1001/jamainternmed.2025.5436. Online ahead of print.

Liset Olarte^{1

2}, Daniel M Musher^{3

4}, Maria C Rodriguez-Barradas^{3

4}

¹ Division of Infectious Diseases, Texas Children's Hospital, Houston.
² Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
³ Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
⁴ Department of Medicine, Baylor College of Medicine, Houston, Texas.

No abstract available

Plain language summary

This Clinical Insights describes updated pneumococcal conjugate vaccines and their recommended use in adults.